UPMC Enterprises’ Portfolio Company, Novasenta, Takes Flight
UPMC Enterprises is proud to officially announce that a new portfolio company, Novasenta, has opened its doors to a new laboratory space on Technology drive in Pittsburgh. Novasenta discovers novel therapeutic targets to transform medicine in cancer and other debilitating diseases by using a proprietary, comprehensive screening platform.
Werewolf Therapeutics launches as publicly traded company
Werewolf Therapeutics, a biopharmaceutical company pioneering the development of therapeutics to stimulate the body’s immune …
UPMC Enterprises Invests in Code Biotherapeutics, a Gene Therapy Startup
Developing targeted non-viral vector gene therapies for rare and prevalent diseases
A Year in Review: A comprehensive look at UPMC Enterprises 2020
Over the last year, UPMC Enterprises, our portfolio companies, and select partners have all supported UPMC’s mission of Life Changing Medicine. In the booklet below, we have compiled highlights from a truly unique year and recognize the team members and projects that have enabled our success.
New president named for UPMC Enterprises
Jeanne Cunicelli has been named president of UPMC Enterprises succeeding Tal Heppenstall, who is retiring from UPMC after 17 years.
Establishing a New Standard of Care: Translating Scientific Discovery into Novel Therapies
As the complexity of science and subsequent treatments increase, the way in which we foster …
UPMC Enterprises announces $1 billion commitment to life sciences investments
With $1 billion to invest in life sciences startups, UPMC Enterprises will create a significant impact on patient care at UPMC while generating major financial returns that will fuel more scientific discoveries.
Comprehensive Genetic Sequencing in Clinical Care: How to Get it Right
At UPMC, we are committed to building a health system where the right patient gets the right care, in the right way, at the right time, every time. The “Rights” of clinical management…
A Look to the Future
As 2019 comes to a close, we have seen many different trends and topics discussed on our blog. From new technologies and investments to breakthroughs in the digital health industry, we wanted to know what our team was most excited to see in 2020.
2019 at a Glance: Growing science focus, portfolio company launches, and an IPO punctuate successful 2019 for UPMC Enterprises
It has been a busy year at UPMC Enterprises. Here at the innovation and commercialization …